Grant: Collaborative Research and Training Experience
The University of British Columbia
$150,000.00
NSERC CREATE in ImmunoEngineering (ImmunoE)
EF 2024-25
Résumé
The recent COVID-19 pandemic underscored a pressing issue: the Canadian Biotechnology industry faces a significant shortage of highly qualified personnel (HQP) equipped with the relevant expertise to develop, produce, and deliver next-generation immunotherapeutics. With the increasing demand for advanced biotechnologies and immunotherapeutics, coupled with the unprecedented growth in the life-sciences and bioengineering sectors of the biotechnology industry, the current generation of skilled HQP is insufficient to meet the needs of Canada's expanding bioeconomy. This NSERC Collaborative Research and Training Program in ImmunoEngineering (ImmunoE) aims to address this shortage by training skilled HQP in the life sciences and bioengineering fields. ImmunoE builds on an established network of interdisciplinary academic and industry life scientists and engineers with expertise in immunology, cell, molecular, and genetic engineering, and biotechnology that was developed under the UBC Immunotherapeutics Research Excellence Cluster. We will leverage this network and its connections with the B.C. biotechnology industry, to train a new generation of interdisciplinary immunoengineers to innovate, develop and deliver new immunoengineering technologies for commercialization. ImmunoE is led by an interdisciplinary and diverse group of excellent established and early career researchers with a track record of inclusive training practices. It will collaborate with industry partners to train a diverse cohort of graduate students in the latest cutting-edge technologies, and provide tailored professional development, inclusive mentorship, and unique networking opportunities to create value-added training for those in the natural sciences and engineering (NSE) fields and at the NSE-Health interface. ImmunoE will accelerate the biotechnology pipeline from research innovation to industry, and train over 80 highly skilled, HQP with industry-ready technical expertise, problem-solving and professional skills, ready for productive careers in the biotechnology industry.
Programme
Collaborative Research and Training Experience
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
584988-2024
Name nom
Zandstra, Peter W
Department département
Biomedical Research Centre (The)
Organization id
2
Institution établissement
The University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
150000
Program id
CREAT
Program name en
Collaborative Research and Training Experience
Program name fr
Programme de formation orientée vers la nouveauté, la collaboration et l'expérience en recherche
Group en
RESEARCH TRAINING AND TALENT DEVELOPMENT
Group fr
FORMATION EN RECHERCHE ET PERFECTIONNEMENT DES COM
Committee code
1078
Committee name en
CREATE Program
Committee name fr
Programme FONCER
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
NSERC CREATE in ImmunoEngineering (ImmunoE)
Keywords
biomaterials; biotechnology; cellular engineering; gene/cell therapy systems; immune targeting; immunoengineering; immunology; nucleic acid bioengineering; stem cell bioengineering
Application summary
The recent COVID-19 pandemic underscored a pressing issue: the Canadian Biotechnology industry faces a significant shortage of highly qualified personnel (HQP) equipped with the relevant expertise to develop, produce, and deliver next-generation immunotherapeutics. With the increasing demand for advanced biotechnologies and immunotherapeutics, coupled with the unprecedented growth in the life-sciences and bioengineering sectors of the biotechnology industry, the current generation of skilled HQP is insufficient to meet the needs of Canada's expanding bioeconomy. This NSERC Collaborative Research and Training Program in ImmunoEngineering (ImmunoE) aims to address this shortage by training skilled HQP in the life sciences and bioengineering fields. ImmunoE builds on an established network of interdisciplinary academic and industry life scientists and engineers with expertise in immunology, cell, molecular, and genetic engineering, and biotechnology that was developed under the UBC Immunotherapeutics Research Excellence Cluster. We will leverage this network and its connections with the B.C. biotechnology industry, to train a new generation of interdisciplinary immunoengineers to innovate, develop and deliver new immunoengineering technologies for commercialization. ImmunoE is led by an interdisciplinary and diverse group of excellent established and early career researchers with a track record of inclusive training practices. It will collaborate with industry partners to train a diverse cohort of graduate students in the latest cutting-edge technologies, and provide tailored professional development, inclusive mentorship, and unique networking opportunities to create value-added training for those in the natural sciences and engineering (NSE) fields and at the NSE-Health interface. ImmunoE will accelerate the biotechnology pipeline from research innovation to industry, and train over 80 highly skilled, HQP with industry-ready technical expertise, problem-solving and professional skills, ready for productive careers in the biotechnology industry.